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Summary: The specificity of the amidase and kininogenase methods for determining rat urinary kallikrein
was studied. Male and female rat urine was employed. Esterase AI, A2 and kallikrein were separated by
DEAE-Sephadex A-50 chromatography. Esterase AI showed no amidase activity towards the Substrate H-£>-
Val-Leu-Arg-/?-nitroanilide. In contrast, esterase A2 and kallikrein attacked the Substrate, and the activity of
kallikrein was especially inhibited by aprotinin, while esterase A2 was more sensitive to soybean trypsin
inhibitor. Esterase AI did not show kininogenase activity, whereas esterase A2 showed this activity, but only
towards the dog plasma Substrate. Kallikrein possessed kininogenase activity towards both dog and rat
plasma kininogen. We believe that the most specific method for measuring rat urinary kallikrein activity is
the kininogenase method using partially purified rat plasma kininogen.
Introduction
The determination of rat urinary kallikrein1),2) has
been used äs an Index of activity in the renal kalli-
krein-kinin System. The activity of this enzyme has
been measured by bioassay in the rat isolated Uterus
(l, 2), by its esterase activity upon synthetic arginine
esters (3) and by its kininogenase activity towards
heated plasma or purified fractions from bovine, dog
or rat plasma (4, 5). More recently, with the availabil-
ity of synthetic Substrates, in which a specific amino
acid sequence is coupled to a chromophore (6), the
amidase method gained favour, because it was
quicker and easier to apply. However, three esterase
activities have been described in rat urine: esterase
AI, esterase A2, and kallikrein (7). It has been re-
ported that esterase A2, a plasminogen activator, also
has kininogenase activity (7, 8).
The purpose of this work was to evaluate the speci-
ficity of the amidase method using the Substrate H-D-
Val-Leu-Arg-/7-nitroanilide (S-2266), and that of the
kininogenase method using partially purified kinino-
gen from dog and rat plasma.
Materials and Methods
Chemicals
The following materials were obtained from commercial
sources: Lima bean trypsin inhibitor (type II-L), Soybean tryp-
sin inhibitor (type II-S), human at-proteinase inhibitor ("ar
antitrypsin"), aprotinin, trypsin (type XIII: TPCK1) treated)
and bradykinin (Sigma); S-2266 (Kabi Vitrum, Stockholm,
Sweden); DEAE-Sephadex A-50 (Pharmacia Fine Chemicals);
Ne-p-tosyl-arginine methyl ester (Schwarz Mann); bradykinin
a-ntibody was a gift from Dr. O. Carreiero, Henry Ford Hospi-
tal, Detroit.
Abbreviations
KIU: Kallikrein inhibitor units. S-2266: H-D-Val-Leu-Arg-
jp-nitroanilide. TAME: />-tosyl-JL-arginine methyl ester HC1.
TPCK: JL-l-toxylamide-2-phenylethyl chloromethyl ketone.
Enzymes
Trypsin (EC 3.4.21.4). Tissue kaUikrein (EC 3.4.21.35).
Experimental procedure
Collection of rat urine
Sprague-Dawley male and female rats were employed. Urine
was collected under toluene over 24 h. The urine was filtered
and dialysed against distilled water for 48 h, then lyophilized.
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The sample of lyophilized urinc was resuspended at one tenth
of the initial volumc in 0.01 mol/1 sodium phosphate buffer pH
7.0, 0.05 niol/l NaCl.
Chromatographie Separation ofesterases
A. Concentrated urine (10 ml) from male or female rats was
applied to a DEAE-Sephadex A-50 colunin (0.6 χ 20.0 cm)
according to MC Partland sl al. (7). The eluate was collected
in three pools: tubes l to 10, 11 to 20 and 21 to 30,
corresponding to esterases Aj, A2 and kallikrein, respec-
tively. These pools were dialysed against 0.01 mol/1 Tris
HC1 buffer pH 7.0 for 24 h. Esterase and amidase activities
were then determined in each pool, and the recovery was
calculated.
B. Concentrated male rat urine (60 ml) was applied to a DEAE-
Sephadex A-50 column (2.2 χ 12.1 cm) equilibrated in 0.01
mol/I sodium phosphate buffer pH 7.0, 0.05 mol/1 NaCl.
The sample was applied and the colunin, which was then
washed with 90 ml of the equilibration buffer, followed by
a 500 ml gradient of 0.01 mol/1 phosphate buffer pH 7.0
from 0.05 mol/1 NaCl to 0.6 mol/1 NaCl, with a flow rate
of 35 ml/h. Three pools of eluted fractions were made: tubes
5 to 19 were considered for esterase Aj, tubes 32 to 51 for
esterase A2, and tubes 75 to 103 for kallikrein. These pools
were dialysed against distilled water for 24 h before deter-
mining their enzymatic activities, which were used to calcu-
late the recovery.
Analy t ica l Methods
Esterase activity
The TAME1) colorimetric assay (substrate: Nflt-Jp-tosyl-arginine
methyl ester) employed by Nustad & Pierce was applied (9).
Activity was expressed s μπιοί of Substrate consumed per
minute of incubation and per liter of the eluate (U/l).
Amidase activity
The method described by Amundsen et al. (10) was used. Ali-
quots of urine or of the eluate from the column were incubated
with 0.1 μπιοί H-/)-Val-Leu-Arg-/?-nitroanilide (S-2266) for 30
min in 0.2 mol/1 Tris-HCl buffer pH 8.0, final volume of l ml,
in the absence of aprotinin. The reaction was stopped with 0.1
ml 50% acetic acid and the absorbance was read at 405 nm. The
activity was expressed in μιηοΐ ofp-nitroaniline (8405 = 1050m2/
mol) formed in one min of incubation per liter of the eluate or
urine (U/l).
Inhibition studies
Aliquots of the A2 esterase pool, with an amidase activity of
0.58 ± 0.02 nmol/min and of the kallikrein pool with an
amidase activity of 0.54 ± 0.02 nmol/min were incubated with
soybean trypsin inhibitor or Lima bean trypsin inhibitor (final
concentration 2.5 to 50 mg/1), aprotinin (final concentration 25
to 500 KlU/ml), or α,-proteinase inhibitor (final concentration
0.5 to 50 mg/1) for 30 min at 37 °C in 0.2 mol/1 Tris-HCl buffer
pH 8.0, final volume 0.9 ml. The substrate S-22661) was then
added and the amidase method was resumed.
Kininogenase activity
A modification of the method described by Carretero et al.
(11) was used. One aliquot of the enzyme was incubated with
kininogen (capable of generating 500 ng kinins) in 0.05 mol/1
sodium phosphate buffer pH 7.4, 0.15 mol/1 NaCl, 3mmol/l
EDTA, l mraol/1 -phenanthroline, 250 mg/1 NaN3, in a final0
volume of 0.5 ml for 15 min. The reaction was stopped with
2 ml 960 g/l ethanol. The precipitate was washed with l ml 960
g/l ethanol. The supernatants containing the kinins were dried
in a bath at 50 °C under a stream of air. The residue obtained
was resuspended in l ml 0.1 mol/1 Tris-HCl pH 7.4,2 g/l gelatin,
250 mg/1 NaN3 and the amount of kinins determined by radio-
immunoassay. Enzymatic activity was expressed s mg of kinins
produced per minute of incubation per liter of the eluate (nag/
min -1). · r
Kininogen preparation
The citrated plasma from rat or dog blood was heated to
56 °C—60 °C for 3 hours, followed by addition of solid ammo-
nium sulphate (114 g/l) to 0.25 Saturation. The mixture was
stirred for one hour at room temperature, then centrifuged at
12100g for 10 min; the supernatant was again precipitated
with ammonium sulphate (125 g/l) at 0.43 Saturation. The
precipitate was resuspended and dialysed against distilled water
a t 4 °C for 48 h. It was then submitted to a Chromatographie
Separation on DEAE-Sephadex A-50, previously equilibrated
with 0.02 mol/1 phosphate buffer pH 6.3, 0.05 mol/1 NaCl. The
fraction contairiing kininogen was eluted with a linear gradient
ranging from 0.05 mol/1 to 0.5 mol/1 NaCl. It was iraally
dialysed and lyophilized. The kininogen content was estimated
by incubation with an exeess of trypsin or rat urinary kallikrein.
The kinin content of dog kininogen per mg protein was 1400
ng with trypsin and 1152 ng with kallikrein, while the kinin
content of rat kininogen was 409 ng with trypsin and 126 ng
with kallikrein. Heated rat plasma and the kininogen prepafa-
tions did not show kininase activity when incubated under the
conditions of the kininogenase assay.
Radioimmunoassay for kinins
Briefly, the samples or Standards were incubated in 0.1 mol/i
Tris-HCl pH 7.4, 2 g/l gelatin, 250 mg/1 sodium azide with
bradykinin antiserum (1:40000 and [125I]bradykimn (10000
counts/min) in a final volume of 0.6 ml at 4 °C for 20 h. One
ml of dextran coated charcoal iri barbital buffer pH 7.4 was
then added, and after centrifugation at 4810 # for 20 min the
supernatant was separated and counted in a Gamma LKB
counter. The sensitivity of the RIA was 10 pg with an intraassay
variability coefficient of 4.2% and an interassay variability
coefficient of 6.7%.
Protein determination
Protein was measured by absorbance at 280 nm and by the
method of Lowry et al. Bovine serum albumin was used s
Standard (12).
Conductivity determination
The conductivity of DEAE-Sephadex A^5Q chromatography
fractions was measured at 25 °C with a Radiometer conduetiv-
ity meter, Copenhagen Type CDM 2e.
Results
sing DEAE-Sephadex chromatography, three peaks
of TAME esterase activity were found in the urine of
male rats and two peaks in the urine of female rats
(fig. l a and l b). The peak that eluted at a concentra-
tion of 0.05 mol/1 NaCl was present only in male
rats, and did not show any ^amidase activity with
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Fig. 1. DEAE-Sephadex A-50 chromatography with stepwise elution of rat urine.
Elution profile of the esterase (Substrate: /?-tosyl-L-arginine methyl ester hydrochloride, o —o) and amidase (substrate:
H-D-Val-Leu-Arg-/?-nitroanilide, o —o) activities.
(a) male rat urine; the flow rate was 24 ml/h. Fractions (l ml) were collected, and fractions l to 10, 11 to 20 and 21 to
30 were pooled.
(b) female rat urine; the flow rate was 9 ml/h; fractions were collected and pooled äs for male rat urine.
D-Val-Leu-Arg-/?-nitroanilide. In contrast, the peaks
that eluted at concentrations of 0.2 mol/l and 0.5
mol/l NaCl, corresponding to esterase A2 and kalli-
krein, did contain amidase activity from both male
and female rats. The peak of esterase A2 accounted
for 16.9% of the total amidase activity present in the
urine of male rats and for 14.8% of that present in
female rats.
We believe that the esterase A2 ffaction is free from
renal kallikrein, since the results from chromatogra-
phy with stepwise elution were confirmed by a gra-
dient elution proeedüre, which gave better resolution.
Repetition of this procedure shpwed that the esterase
A2 fraction.always showed kininogenase activity (see
fig. 4). We submitted the esterase A2 fraction to
Western blpt analysis with polyclonal antibody
against rat urinary kallikreinj and the results were
negative. It has been reported that highly purified
esterase. A2 shows kininogenase activity towards
heated dog plasm;a (8,14).
The recovery öf amidase activity was 92.7% for male
rat urine and 72.9% for female rat urine.
The pattern of Inhibition of these amidase activities
was studied against some trypsin Inhibitors in order
to selectively inhibit one of the two enzymes. The
amidase activity of esterase A2 proved to be more
sensitive than that of kallikrein to soybean trypsin
inhibitor (fig. 2); on the other hand, the latter was
more sensitive than esterase A2 to aprotinin (fig. 3).
However, none of these Inhibitors is specific for any
of these enzymes. In fact, soybean trypsin inhibitor
at 50 mg/1, which inhibited 85.9% of the esterase
A2 activity, also inhibited kallikrein up to 12.3%.
Likewise, aprotinin concentrations (50, 100 and 200
KlU/ml) that inhibited kallikrein up to 95.8%, 98.8%
and 99.5%, respectively, also inhibited esterase A2 up
to 30%, 43.5% and 61%. Lima bean trypsin inhibitor
and ai-antiproteinase did not inhibit the amidase
activity either of esterase A2 or of kallikrein at the
concentrations employed.
The study of the ability of the fractions containing
esterase Als A2 and kallikrein to generate kinins from
kininogen ff om dog or rat plasma was carried out in
urine from male rats. This urine was submitted to
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Fig. 2. Inhibition of the two amidase activities (substrate: H-Z>-
Val-Leu-Arg-p-nitroanilide) present in rat urine by
soybean trypsin inhibitor.
Aliquots of esterase A2 fraction (a) with an amidase
activity of 0.58 ± 0.02 nmol/min and of kallikrein frac-
tion (D) with an amidase activity of 0.54 ± 0.02 nmol/
min were incubated with increasing concentration of
soybean trypsin inhibitor ( s described in Materials and
Methods). Values are expressed s χ ± S. D. of three
determinations.
Chromatographie Separation with a gradient elution
in order to better resolve the peaks of enzymatic
activity. It was found that the first peak of esterase
activity had no kininogenase activity. However, the
two peaks of esterase activities, which also possessed
amidase activity, also hydrolysed dog kininogen. In
contrast, rat kininogen from faeated plasma, or the
partially purified fraction of kininogen, was hydro-
lysed only by kallikrein (fig. 4). The ratios of kinino-
genase activity/amidase activity when using the dog
1.00
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375 500
2.0 4.0
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Fig. 3. Inhibition of the two amidase activities present in rat
urine by aprotinin.
The conditions were the same s those described in the
legend to figure 2, except that aprotinin was used in-
stead of soybean trypsin inhibitor. (·) esterase A2 frac-
tion; (a) kallikrein fraction. Values are expressed s
χ ± S. D. of three determinations.
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Fig. 4. Chromatography of male rat urine in DEAE-Sephadex
A-50 with gradieftt elution.
The flow rate was 35 ml/h and 5ml fr ctions were
collected. The afrow indicates the beginning of the
elution gradient from 0.05 mol/1 NaCl to 0.5 mol/l NaCl
in 0.01 mol/1 sodium phosphate buffer pH 7.0.
a) Plot of A2so (·—·)» NaCl eoncentrations (·—·) and
esterase activity (substrate: /j-tosyl-L-arginine methyl
ester hydrochloride, o·—o). NaCl concentration in the
eluate was estimated from conductivity measurements.
b) Plot of amidase aetivity (subistrate: H-jD-Val-Leu-
Arg-p-nitroanih'de, Φ^·) and kininogenase activity
towards dog kini ogen (Δ) and towards rat kininogen
(*)·Fractions p oled were: 5—19 for esterase AI; 32—51
for esterase A2; and 75—103 for kallikrein.
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Substrate were 0.026 and 0.027 (kinin, mg/min
nitroaniline, /min · 1) for esterase A2 and kalli-
krein, respectively, and these values are similar to
those found in whole urine (0.025). When using rat
kininogen äs the Substrate, the ratios were 0 and
0.048, respectively. Neither esterase A2 nor kallikrein
showed kininase activity. The recovery of amidase
activity was 84.3%, while that of kininogenase activ-
ity was 68.7% with dog kininogen, and 67.2% with
rat kininogen.
Discussion
Three esterase activities were found in the urine of
male rats: AI, A2 and kallikrein, whereas female rat
urine had no esterase Aj activity. According to our
results, esterase A2 showed amidase activity towards
the synthetic Substrate S-2266. Using this Substrate,
it was shown that esterase A2 accounted for about
15% of the total amidase activity present in the urine
j of both male and female rats. This value was similar
1
 to that described by Takaoka et al. in Wistar rat urine
; when using the synthetic Substrate Pro-Phe-Arg-4-
i methylcoumaryl-7-amide (13).
l
The study of the Inhibition of the two amidase activi-
| ties present in urine revealed that esterase A2 was
!
 inhibited more by soybean trypsin inhibitor than by
aprotinin, whereas kallikrein was more inhibited by
aprotinin than by soybean trypsin inhibitor. More-
over, using similar initial activities of esterase A2 and
kallikrein, soybean trypsin inhibitor inhibited esterase
A2 more than kallikrein at the same concentrations
of the inhibitor, whereas aprotinin inhibited the latter
more than esterase A2. These results are fully consist-
ent with those described by Nustad & Pierce (9) for
the esterase activity of these enzymes. Nonetheless,
in contrast with our results, McPartland et al. found
that the arginine esterase activity of esterase A2 is
more inhibited by aprotinin than by soybean trypsin
inhibitor (14). On the other hand, Morimoto et al.
found that the amidase activity of esterase A2 with
Pro^Phe-Arg-4-methylcoümaryl-7-amide is more in-
hibited by soybean trypsin inhibitor than that of
kallikrein, which agrees with the data presented here.
However, their results on aprotinin are at variance
with öurs, since they found that both enzymes are
inhibited to a similar extent by this inhibitor (15).
These discrepancies are possibly due to the different
Substrate used to determine enzymatie activity and
to the degree of purity of the enzymatie fractions
employed, since the presence of other proteins can
modify the sensitivity of the enzyme to the inhibitors
(14).
It must be emphasized that in our experiments, in
which similar activities of esterase A2 and kallikrein
were incubated with increasing amounts of aprotinin,
we observed that an aprotinin concentration of 50
KlU/ml inhibited kallikrein by 95.9% and left a rem-
nant esterase A2 activity of 70%. On the light of
these findings, the specificity of the amidase method
published by Amundsen et al. (10) for the determina-
tion of rat urinary kallikrein seems to be highly ques-
tionable. It is doubtful whether this method is selec-
tive for this enzyme if the sample is read against a
blank in the presence of 10 KIU or 50 KIU aprotinin
(10, 16, 17).
On the other hand, esterase A2, äs well äs kallikrein,
were able to release kinins from partially purified dog
kininogen, which is in agreement with the findings of
McPartland ei al. (7, 14), Nustad & Pierce (9), Chao
et al. (8) and Morimoto et al. (15). Both urine and
the isolated fractions of esterase A2 and kallikrein
showed the same ratio kininogenase activity/amidase
activity. It is then reasonable to assume a good corre-
lation between the kininogenase method using dog
Substrate and the amidase method described by
Amundsen et al. (10), an argument that has been used
to validate the determination of urinary kallikrein
by the amidase method (17). This implies that the
kininogenase method using Substrate from dog
plasma is äs unspecific äs the amidase method for
the determination of rat urinary kallikrein activity.
Obviously, the most important finding reported here
is that esterase A2 was unable to release kinins from
heated rat plasma and from partially purified rat
kininogen. These results agree with those of McPart-
land et al. (7) and Nustad & Pierce (9) who did not
observe any change in the pressor test in the rat when
injecting the A2 fraction. This different behaviour of
esterase A2 towards the dog and rat Substrates might
be due to the specificity of the Substrate. However,
we cannot rule out the existence of an inhibitor in
the preparation of rat kininogen that may fully inhibit
fraction A2. Studies are in progress to help elucidate
this point.
The determination of rat urinary kallikrein activity
may be rendered selective by using either the amidase
or kininogenase assay on dog kininogen applied to
urine previously subjected to a Chromatographie Sep-
aration (18).
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